| Efficacy and safety of pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide in the treatment of recurrent ovarian cancer: a phase 2 nonrandomized … E Zsiros, S Lynam, KM Attwood, C Wang, S Chilakapati, EC Gomez, S Liu, ... JAMA oncology 7 (1), 78-85, 2021 | 127 | 2021 |
| Ultrarestrictive opioid prescription protocol for pain management after gynecologic and abdominal surgery J Mark, DM Argentieri, CA Gutierrez, K Morrell, K Eng, AD Hutson, ... JAMA network open 1 (8), e185452-e185452, 2018 | 123 | 2018 |
| Intracerebroventricular injection of neuropeptide FF, an opioid modulating neuropeptide, acutely reduces food intake and stimulates water intake in the rat D Sunter, AK Hewson, S Lynam, SL Dickson Neuroscience letters 313 (3), 145-148, 2001 | 102 | 2001 |
| Immunotherapy for gynecologic cancer: current applications and future directions S Lynam, AA Lugade, K Odunsi Clinical obstetrics and gynecology 63 (1), 48-63, 2020 | 32 | 2020 |
| Efficacy of hyperthermic intraperitoneal chemotherapy and cytoreductive surgery in the treatment of recurrent uterine sarcoma TP Díaz-Montes, F El-Sharkawy, S Lynam, A Harper, M Sittig, ... International Journal of Gynecologic Cancer 28 (6), 2018 | 22 | 2018 |
| Primary placement of incisional negative pressure wound therapy at time of laparotomy for gynecologic malignancies S Lynam, KS Mark, SM Temkin International Journal of Gynecologic Cancer 26 (8), 2016 | 21 | 2016 |
| Risk, risk reduction and management of occult malignancy diagnosed after uterine morcellation: a commentary S Lynam, L Young, V Morozov, G Rao, DM Roque Women’s Health 11 (6), 929-944, 2015 | 13 | 2015 |
| Implementation of a restrictive blood transfusion protocol in a gynecologic oncology service. J Mark, S Lynam, K Morrell, K Eng, K Starbuck, JB Szender, E Zsiros, ... Gynecology and reproductive endocrinology 3 (1), 1, 2019 | 4 | 2019 |
| Video-based counseling and point-of-contact testing improves genetic screening completion in an ovarian cancer patient population S Lynam, J Dowling, M Hutton, H Wypij, K Odunsi, SB Lele, E Zsiros, ... Gynecologic Oncology 159, 301-302, 2020 | 1 | 2020 |
| Breaking the silence: Burnout among gynecologic oncology trainees is an impending crisis S Lynam, PC Mayor, KH Eng, JE Mark, K Starbuck, SB Lele, PJ Frederick, ... Gynecologic Oncology 154, 9-10, 2019 | 1 | 2019 |
| How much is too much? Ending excessive opioid prescribing after major gynecologic oncology procedures JE Mark, D Phoenix, K Morrell, KH Eng, PC Mayor, K Starbuck, S Lynam, ... Gynecologic Oncology 154, 13-14, 2019 | 1 | 2019 |
| Surgery induces broad changes in clinically relevant genes regulating immune and metabolic responses in murine epithelial ovarian cancer PC Mayor, SN Akers, PJ Frederick, SB Lele, EC Gomez, J Wang, S Lynam, ... Gynecologic Oncology 154, 36, 2019 | 1 | 2019 |
| Role of Tumor Markers S Lynam, S Lele Preventive Oncology for the Gynecologist, 233-244, 2019 | 1 | 2019 |
| Gynecologic cancer care in the first year of the COVID-19 pandemic GC Chapman, SA Smrz, JC Gordon, SK Lynam, AE Strohl, LA Ferguson, ... Gynecologic Oncology 178, 138-144, 2023 | | 2023 |
| Chronic fatigue and physical distress influence the outcomes of immunotherapy treatment in patients with recurrent ovarian cancer S Lynam, C Wang, K Odunsi, E Zsiros Gynecologic Oncology 162, S109, 2021 | | 2021 |
| Increased physical activity promotes CD8+ lymphocyte infiltration and improves survival in a murine model of ovarian cancer S Lynam, AE Stenzel, E Zsiros, A Sen, K Odunsi Gynecologic Oncology 159, 12-13, 2020 | | 2020 |
| Utilization and prognostic impact of somatic tumor testing in ovarian cancer: A single-institution experience S Lynam, FO Recio, M Roy, S Belliotti, SN Akers, PJ Frederick, SB Lele, ... Gynecologic Oncology 159, 29, 2020 | | 2020 |
| Unfitness and cancer: State-of-the-art activity tracking devices reveal the unexpectedly sedentary lives of our cancer patients S Lynam, PC Mayor, M Roy, JE Mark, K Starbuck, PJ Frederick, SB Lele, ... Gynecologic Oncology 154, 194, 2019 | | 2019 |
| Primary placement of incisional negative pressure therapy at time of laparotomy for gynecologic malignancies S Lynam, K Mark, SM Temkin Gynecologic Oncology 141, 87, 2016 | | 2016 |
| Efficacy of hyperthermic intraperitoneal chemotherapy and cytoreductive surgery in treatment of recurrent uterine sarcoma. S Lynam, T Diaz-Montes, A Harper, M Sittig, R MacDonald, V Gushchin, ... Journal of Clinical Oncology 34 (15_suppl), e17122-e17122, 2016 | | 2016 |
